Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (32) | B (18) | C (20) | D (33) | E (32) | F (11) | G (7) | H (9) | I (21) | K (1) | L (23) | M (12) | N (6) | O (10) | P (25) | R (12) | S (21) | T (26) | U (2) | V (12) | Z (4)
Generic Name Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)sort icon
Safinamide Onstryv Monoamine oxidase B inhibitor 2019/07/10
Risankizumab Skyrizi Interleukin-23 inihbitor 2019/05/13
Suvorexant Belsomra Hypnotic 2019/04/16
Enasidenib IDHIFA Antineoplastic agent / IDH2 Inhibitor 2019/02/27
Buprenorphine Sublocade Partial opioid agonist 2019
Doravirine + Lamivudine + Tenofovir Delstrigo Antiviral agent 2018/12/15
Burosumab Crysvita Fibroblast growth factor 23 (FGF23) Inhibitor 2018/12/05
Doravirine Pifeltro NNRTI 2018/11/15
Ivermectin Stromectol Anthelmintic 2018/11/07
Elagolix Orilissa Gonadotropin releasing hormone receptor antagonist 2018/10/31
Telotristat ethyl Xermelo Tryptophan hydroxylase inhibitor 2018/10/12
Cabozantinib Cabometyx Antineoplastic agent 2018/09/14
Crisaborole Eucrisa PDE-4 inhibitor 2018/08/29
Baricitinib Olumiant Immunosuppressant 2018/08/17
Erenumab Aimovig Anti-calcitonin gene-related peptide receptor 2018/08/01
Brigatinib Alunbrig Antineoplastic agent 2018/07/26
Ivacaftor + tezacaftor Symdeko Cystic Fibrosis Transmembrane Conductance Regulator Correctors and Potentiators 2018/06/27
Iron isomaltoside Monoferric Iron preparation 2018/06/22
Liraglutide + Insulin Degludec Xultophy Incretin mimetic + insulin 2018/06/06
Ertugliflozin + metformin Segluromet Oral blood glucose lowering agents 2018/05/30
Benzocaine Orajel teething products 2018/05/23
Ertugliflozin Steglatro Sodium-glucose co-transporter 2 (SGLT2) inhibitor 2018/05/23
Ertugliflozin + sitagliptin Steglujan Oral blood glucose lowering agents 2018/05/22
Apomorphine Movapo Nonergot-derivative dopamine receptor agonist 2018/04/xx
Buprenorphine Probuphine Opiate partial agonist 2018/04/18
Glycopyrrolate Cuvposa Antimuscarinic antispasmodic agent 2018/04/03
Ixekizumab Taltz Immunomodulator 2018/03/29
Benralizumab Fasenra Respiratory agent 2018/03/28
Saxagliptin + dapagliflozin Qtern Oral antihyperglycemic agent 2018/03/20
Ceftobiprole Zevtera Cephalosporin antibiotic 2018/03/20
Flibanserin ADDYI CNS agent 2018/02/27
Semaglutide Ozempic Incretin mimetic 2018/02/22
Naltrexone + bupropion Contrave Anorexigenic agents 2018/02/13
Buprenorphine Belbuca Opioid analgesic 2018/01/17
Migalastat Galafold Various alimentary tract and metabolism products 2018/01/15
Lifitegrast Xiidra Lymphocyte function associated antigen-1 (LFA-1) antagonist 2017/12/22
Syndicate content